Particle.news
Download on the App Store
16 ARTICLES
·
1h ago

Trump Unveils TrumpRx, a Government Portal Linking Patients to Drugmaker Discounts

The site routes shoppers to manufacturers’ cash-pay channels under deals that traded tariff relief for lower prices.

TrumpRx is a key component of President Donald Trump's efforts to lower drug prices.
US President Donald Trump speaks in the Oval Office of the White House in Washington, DC, US, on Tuesday, Sept. 30, 2025. Pfizer will sell some drugs at a 50% average discount on a direct-to-consumer website called TrumpRx, an initiative intended to allow Americans to pay for prescriptions at discounted rates negotiated by the government.

Overview

  • The portal is set to go live Thursday evening and serves as a facilitator rather than a pharmacy, directing users to buy directly from participating drugmakers.
  • Officials and reports indicate purchases will be cash-only and not processed through insurance, positioning the site as a self-pay option.
  • At least 16 manufacturers have signed on, with announced cash prices for some drugs such as Wegovy and Zepbound at about $149 per month, Repatha at $239, and Januvia at $100, though a full list and many prices are still undisclosed.
  • Experts say savings are most likely for uninsured people or those with high deductibles, while many insured patients may still pay less through their health plans.
  • An FTC settlement with Express Scripts would allow certain TrumpRx payments to count toward deductibles and out-of-pocket maximums if specified regulatory changes occur, and key details such as discount duration remain unresolved.